Learn more →
Back to Expert Scholars
hematopoietic-transplant / hematopoietic-transplantAllogeneic Stem Cell Transplantation

Miguel-Angel Perales

米格尔-安赫尔·佩拉莱斯

MD

🏢Memorial Sloan Kettering Cancer Center(纪念斯隆-凯特琳癌症中心)🌐USA

Chief, Adult Bone Marrow Transplant Service (Interim); Professor of Medicine成人骨髓移植科代主任,医学教授

65
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Miguel-Angel Perales is a leading authority in allogeneic hematopoietic cell transplantation and GvHD prevention at MSKCC. His research has refined T-cell depletion strategies, post-transplant cyclophosphamide platforms, and integration of CAR-T therapy with transplant, improving outcomes across diverse hematologic malignancies.

Share:

🧪Research Fields 研究领域

Allogeneic Transplant异基因移植
GvHD Prevention移植物抗宿主病预防
T-cell DepletionT细胞清除
CAR-T TherapyCAR-T治疗

🎓Key Contributions 主要贡献

T-Cell Depletion and GvHD Prevention

Advanced CD34-selected graft engineering at MSKCC, achieving very low rates of severe GvHD while maintaining potent graft-versus-leukemia effects in high-risk disease.

Post-Transplant Cyclophosphamide

Led trials applying post-transplant cyclophosphamide to matched and mismatched unrelated donor settings, expanding access to transplantation.

CAR-T and Transplant Integration

Pioneered clinical trials examining CAR-T cell therapy as a bridge to or consolidation after allogeneic transplant in relapsed/refractory lymphoma and leukemia.

Representative Works 代表性著作

[1]

Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplantation: past, present and future

Bone Marrow Transplantation (2021)

Comprehensive review of T-cell depletion strategies defining the current landscape and future directions.

[2]

High-dose post-transplantation cyclophosphamide with tacrolimus and mycophenolate mofetil for HLA-mismatched unrelated donor HCT

Biology of Blood and Marrow Transplantation (2020)

Demonstrated feasibility and efficacy of PTCy-based GvHD prophylaxis in unrelated donor transplants.

[3]

CAR T-cell therapy in large B-cell lymphoma: who should go to transplant?

Hematology (ASH Education Program) (2022)

Framed the clinical decision between CAR-T and autologous transplant in relapsed lymphoma.

🏆Awards & Recognition 奖项与荣誉

🏆Best Abstract Award, American Society for Transplantation and Cellular Therapy
🏆Translational Research Award, MSKCC
🏆Top Oncologist, Castle Connolly

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 米格尔-安赫尔·佩拉莱斯 的研究动态

Follow Miguel-Angel Perales's research updates

留下邮箱,当我们发布与 Miguel-Angel Perales(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment